万隆制药 (873617.OC)

+ 收藏

现金流量表(万隆制药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 124,777,659.23326,503,629.13173,146,968.55435,083,697.07207,929,899.74
 收到的税费返还(元) -13,761.4713,761.471,056,786.18416,203.21
 收到其他与经营活动有关的现金(元) 6,046,803.105,592,414.233,201,577.256,374,727.082,064,910.55
 经营活动现金流入小计(元) 130,824,462.33332,109,804.83176,362,307.27442,515,210.33210,411,013.50
 购买商品、接受劳务支付的现金(元) 28,871,732.1451,412,599.3918,383,000.2843,101,009.2817,307,757.17
 支付给职工以及为职工支付的现金(元) 23,615,550.2952,804,289.3727,392,889.0053,825,263.2828,050,293.22
 支付的各项税费(元) 19,438,311.2438,720,861.8525,008,035.4952,075,350.7923,488,223.98
 支付其他与经营活动有关的现金(元) 45,112,482.50195,484,633.99113,201,527.13265,322,525.72148,409,613.72
 经营活动现金流出小计(元) 117,038,076.17338,422,384.60183,985,451.90414,324,149.07217,255,888.09
 经营活动产生的现金流量净额(元) 13,786,386.16-6,312,579.77-7,623,144.6328,191,061.26-6,844,874.59
二、投资活动产生的现金流量
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) 100,323.007,960.005,260.00565,000.00485,000.00
 投资活动现金流入小计(元) 100,323.007,960.005,260.00565,000.00485,000.00
 购建固定资产、无形资产和其他长期资产支付的现金(元) 84,750.001,122,138.61221,400.003,869,449.142,027,239.19
 投资活动现金流出小计(元) 84,750.001,122,138.61221,400.003,869,449.142,027,239.19
 投资活动产生的现金流量净额(元) 15,573.00-1,114,178.61-216,140.00-3,304,449.14-1,542,239.19
三、筹资活动产生的现金流量
 取得借款收到的现金(元) 100,000,000.0030,000,000.0030,000,000.0030,000,000.0030,000,000.00
 筹资活动现金流入小计(元) 100,000,000.0030,000,000.0030,000,000.0030,000,000.0030,000,000.00
 偿还债务支付的现金(元) 30,000,000.00--30,000,000.00-
 分配股利、利润或偿付利息支付的现金(元) 68,722,291.6630,986,500.0030,346,000.0036,337,249.9835,553,249.99
 筹资活动现金流出小计(元) 98,722,291.6630,986,500.0030,346,000.0066,337,249.9835,553,249.99
 筹资活动产生的现金流量净额(元) 1,277,708.34-986,500.00-346,000.00-36,337,249.98-5,553,249.99
四、汇率变动对现金及现金等价物的影响(元) ----0.06-
五、现金及现金等价物净增加额(元) 15,079,667.50-8,413,258.38-8,185,284.63-11,450,637.92-13,940,363.77
 加:期初现金及现金等价物余额(元) 28,215,652.5036,628,910.8836,628,910.8848,079,548.8048,079,548.80
 期末现金及现金等价物余额(元) 43,295,320.0028,215,652.5028,443,626.2536,628,910.8834,139,185.03
补充资料:
 净利润(元) 13,204,910.44-76,233,337.78-35,983,509.85-26,697,769.22-13,874,404.89
 资产减值准备(元) 8,066,835.6933,260,297.235,108,093.4616,387,702.562,950,364.44
 固定资产和投资性房地产折旧(元) 12,927,680.0026,555,501.1413,438,644.0727,006,379.3013,300,087.28
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 12,927,680.0026,555,501.1413,438,644.0727,006,379.3013,300,087.28
 无形资产摊销(元) 1,165,148.462,614,445.011,357,222.502,714,445.011,357,222.51
 长期待摊费用摊销(元) 1,130,421.362,260,842.721,130,421.362,260,842.721,130,421.36
 固定资产报废损失(元) -46,018.73-7,607.4026,173.58-296,505.12-266,043.45
 财务费用(元) 1,222,291.66983,500.00343,000.001,237,249.98453,249.99
 递延所得税(元) -26,899.37-53,798.73-26,899.36-53,798.72-26,899.38
 递延所得税负债增加(元) -26,899.37-53,798.73-26,899.36-53,798.72-26,899.38
 存货的减少(元) -17,008,067.94-12,939,128.16-7,419,061.41-9,835,361.12-4,325,298.54
 经营性应收项目的减少(元) 1,487,169.9533,988,265.22218,920,409.721,480,320.166,299,626.72
 经营性应付项目的增加(元) -8,308,780.31-15,352,153.15-204,118,901.5214,007,250.98-13,904,607.96
 现金的期末余额(元) 43,295,320.0028,215,652.5028,443,626.2536,628,910.8834,139,185.03
 减:现金的期初余额(元) 28,215,652.5036,628,910.8836,628,910.8848,079,548.8048,079,548.80
 现金及现金等价物的净增加额(元) 15,079,667.50-8,413,258.38-8,185,284.63-11,450,637.92-13,940,363.77
公告日期 2024-08-272024-04-252023-08-252023-04-252022-08-26
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院